The Global Injectable Drug Delivery Devices Market is expected to grow at a CAGR of 11.8% during forecasted period. Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes. According to WHO in 2012, 14.1 million cancer cases around the world were registered out of which 6.7 million were women and 7.4 million were men. This number is expected to increase to 24 million by 2035. Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1211 .
Key players for Global Injectable Drug Delivery Devices Market:
Becton, Dickinson and Company (US), Baxter International (US), Schott AG (Germany), Eli Lilly and Company (US), Pfizer (US), Gerresheimer AG (Germany), Terumo Corporation (Japan), Antares Pharma, Inc. (US), Novo Nordik (Denmark), Sanofi SA (France), Unilife Corporation (US), Zogenix, Inc (US), Hospira, Inc (US), Presage Bioscience (US), MicroCHIPS, Inc (US), Pearl Therapeutics Inc (US), Genentech Inc. (US), Bend Research (US)
Injectable Drug Delivery Devices Market Segmentation:
Global injectable drug delivery devices market is segmented on the basis of type into devices and formulation. Devices are further segmented into self-injection devices and conventional injection devices. By formulation, they are sub segmented into conventional drug delivery, novel drug delivery and others. On the basis of application, the market is segmented into immune disorder, cancer, diabetes, and other. And on the basis of end users the market is segmented into hospitals, homecare, clinics, and other.
Injectable Drug Delivery Devices Market Regional analysis:
Global injectable drug delivery devices market is dominated by America owning to increasing patient population suffering from diabetes and cancer. Increasing aging population and technological development is also supporting the growth of the market. Europe accounts second largest market for injectable drug delivery devices which is followed by Asia Pacific. Huge patient population and rapid development of economies in countries of Asia Pacific is the major driver for the market in this region.
Table of Content for Injectable Drug Delivery Devices Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
ASK Questions to Experts @ https://www.marketresearchfuture.com/enquiry/1211 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312